Development of a psilocin immunoassay for serum and blood samples

18Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.
Get full text

Abstract

After the immunisation of rabbits with a psilocin-specific immunogen, polyclonal antisera were obtained. With these antisera a competitive, heterogeneous radioimmunoassay for the detection of psilocin was developed. As tracer a derivative of psilocin was synthesised, which contained a tritiated CH3 group. The antisera showed a specific reaction with psilocin. The cross-reactivity of structurally related endogenous substances like serotonin, tryptophan and tyrosine was below 0.01%. Also common drugs of abuse (Δ9-tetrahydrocannabinol, cocaine, morphine, amphetamine) showed negligible cross-reactivity (0.01-2%). Only tricyclic neuroleptics with a (dimethylamino)ethyl side-chain showed some cross-reactivity (20%). Spiked serum and blood samples were analysed with this new immunoassay and the results obtained were compared with the values measured with a validated GC-MS method. © Springer-Verlag 2004.

Author supplied keywords

Cite

CITATION STYLE

APA

Albers, C., Köhler, H., Lehr, M., Brinkmann, B., & Beike, J. (2004). Development of a psilocin immunoassay for serum and blood samples. International Journal of Legal Medicine, 118(6), 326–331. https://doi.org/10.1007/s00414-004-0469-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free